ABOUT US
Our services
OUR TRACK RECORD
19 years helping innovative startups
Agoranov fosters the creation of innovative startups by providing a professional and friendly environment and by facilitating their access to expertise, tools and infrastructure crucial to success and rapid growth.
COACHING
COACHING
Coaching provided by an experienced and multidisciplinary team with 15 years expertise in entrepreneurship and startup creation.
ALL-INCLUSIVE ACCOMODATION
ALL-INCLUSIVE ACCOMODATION
2,300 m2 private offices, open-space, laboratories, fully equipped meeting rooms and a cafeteria.
ACCELERATION
ACCELERATION
Our Acceleration program includes training sessions and events: thematic workshops with well-known experts, meetings with investors, corporate actors, « alumni » entrepreneurs, etc., plus various informal gatherings.
COMMUNITY OF ENTREPRENEURS
COMMUNITY OF ENTREPRENEURS
Becoming part of a large and thriving community of entrepreneurs, investors and innovation experts.
ECOSYSTEM
ECOSYSTEM
Agoranov is a key player in the Paris innovation ecosystem.
19 YEARS OF EXPERTISE
19 YEARS OF EXPERTISE
Agoranov has incubated 390 startups, including 5 companies publicly listed, among which CRITEO on the NASDAQ, that now represent 7500 jobs in various industries.
OUR TRACK RECORD
390 PROJECTS INCUBATED
390 PROJECTS INCUBATED
350 STARTUPS CREATED
350 STARTUPS CREATED
€700+M RAISED FROM PRIVATE FUNDS
€700+M RAISED FROM PRIVATE FUNDS
1 NASDAQ (Criteo) & 4 EURONEXT (Anevia, Biophytis, GenSight, Pixium Vision)
1 NASDAQ (Criteo) & 4 EURONEXT (Anevia, Biophytis, GenSight, Pixium Vision)
7000+ JOBS CREATED
7000+ JOBS CREATED
181 laureates of the I-LAB national contest
181 laureates of the I-LAB national contest
Our startups
All
Digital
Industry & Greentech
Health
#A to Z
#Most recent
hillo develops the first AI-based decision support platform for patient with diabetes, based on a patented blood glucose predictive technology that adapts to every patients' physiology and habits. Our technology combines pharmacokinetics models with machine learning algorithms. We develop tools for patients to help them anticipate and avoid hypo- and hyperglycemia, and for health care professionals to help them understand each patients' specific glycemic response. We demonstrated outstanding accuracy of our prediction algorithms through observational trials in hospital.
" data-original='https://www.agoranov.com/wp-content/uploads/2019/04/Logo-hillo-site.jpg' data-date='2017-08-01' style='background-image: url()'>hillo develops the first AI-based decision support platform for patient with diabetes, based on a patented blood glucose predictive technology that adapts to every patients' physiology and habits. Our technology combines pharmacokinetics models with machine learning algorithms. We develop tools for patients to help them anticipate and avoid hypo- and hyperglycemia, and for health care professionals to help them understand each patients' specific glycemic response. We demonstrated outstanding accuracy of our prediction algorithms through observational trials in hospital.
" data-original='https://www.agoranov.com/wp-content/uploads/2019/04/Logo-hillo-site.jpg' style='background-image: url()'>